Metastatic Neoplasm Clinical Trial
Official title:
Psychological and Emotional Impacts of Participation in Oncologic Clinical Trials
This study aims to assess anxiety/depression and life quality of patients included in clinical trials versus patients treated in a standard way.
This study aims to assess anxiety/depression and life quality of patients included in clinical trials versus patients treated in a standard way A case-control study ;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02226289 -
Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment
|
Phase 2 | |
Terminated |
NCT02566421 -
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
|
N/A | |
Terminated |
NCT04418661 -
Safety and Efficacy Study of SAR442720 in Combination With Other Agents in Advanced Malignancies
|
Phase 1/Phase 2 | |
Completed |
NCT00525057 -
Dalteparin in Preventing DVT in Participants With Cancer
|
N/A | |
Terminated |
NCT03871348 -
A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT02775292 -
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
|
Phase 1 | |
Recruiting |
NCT05617716 -
Spine Radiosurgery for Symptomatic Metastatic Neoplasms
|
Phase 2 | |
Active, not recruiting |
NCT05103358 -
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
|
Phase 2 | |
Recruiting |
NCT02560311 -
Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis
|
N/A | |
Completed |
NCT02492711 -
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer
|
Phase 3 |